Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsCorrection: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients, Published online: 14 February 2019; doi:10.1038/s41397-019-0084-2Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

https://www.nature.com/articles/s41397-019-0084-2

Source: The Pharmacogenomics Journal - February 14, 2019 Category: Drugs & Pharmacology Authors: Luz M. Canet Jose M. S ánchez-Maldonado Rafael C áliz Ana Rodr íguez-Ramos Carmen B. Lupia ñez Helena Canh ão Manuel Mart ínez-Bueno Alejandro Escudero Juana Segura-Catena Signe B. Sorensen Merete L. Hetland Mar ía José Soto-Pino Miguel A. Ferrer Source Type: research

More News: Arthritis | Drugs & Pharmacology | Hormones | Rheumatoid Arthritis | Rheumatology